Team:PKU Beijing/Project/AND Gate 2 Design
From 2009.igem.org
(17 intermediate revisions not shown) | |||
Line 2: | Line 2: | ||
{{PKU_Beijing/Sidebar_Project}} | {{PKU_Beijing/Sidebar_Project}} | ||
{{PKU_Beijing/Header2}} | {{PKU_Beijing/Header2}} | ||
- | + | [[Team:PKU_Beijing/Project|Project]] > [[Team:PKU_Beijing/Project/AND_Gate_2|AND Gate 2]] > [[Team:PKU_Beijing/Project/AND_Gate_2_Design|Design]] | |
==='''One of the Second AND Gate Design'''=== | ==='''One of the Second AND Gate Design'''=== | ||
Line 12: | Line 12: | ||
<br><br> | <br><br> | ||
When the bistable switch is in the “NO MEMORY” state, namely the CI434 state, PhiR73 delta/T3pol (amber mutation) mRNA is not expressed. At this time, ring signal alone, though expresses SupD tRNA, has no effect. When the bistable switch is turned to the “MEMORY” state, with the constitutive expression of CI and the increase of PhiR73 delta/T3pol mRNA level, the ring signal can lead to expression of functional PhiR73 delta/T3pol by rescuing the amber mutation in the PhiR73 delta/T3pol protein. | When the bistable switch is in the “NO MEMORY” state, namely the CI434 state, PhiR73 delta/T3pol (amber mutation) mRNA is not expressed. At this time, ring signal alone, though expresses SupD tRNA, has no effect. When the bistable switch is turned to the “MEMORY” state, with the constitutive expression of CI and the increase of PhiR73 delta/T3pol mRNA level, the ring signal can lead to expression of functional PhiR73 delta/T3pol by rescuing the amber mutation in the PhiR73 delta/T3pol protein. | ||
+ | |||
+ | |||
+ | In order to creat a amber mutation inside of the PhiR73 delta/T3pol coding sequence, we carried out site directed mutagenesis with primers introduced with TAG amber mutation at the original Ser site. One problem that comes to us is how to decide which serine codon to mutate. In order to avoid that the half translated protein has function, we picked first few serine of the whole sequence of either PhiR73 delta activator and T3 polymerase. For PhiR73 delta it is on the first and second serine. (For PhiR73 delta sequence click [http://partsregistry.org/Part:BBa_I746352 Here]). In T3 polymerase, we picked four sites, they are on the 37th, 91th, 130th, 283th nucleotide of its coding sequence. | ||
+ | |||
+ | [[Image:PKU_Point_Mutation.png|500px|center|thumb|fi2. Creating the Amber mutation]] | ||
+ | |||
+ | In order to test the second AND Gate we place the mutated PhiR73 delta downstream of the salicylate sensor, so that salicylate can induce the expression of the mutated PhiR73 delta. Because our earlier work is very robust, there are many constructed SupD indicible expression set. We picked Arabinose sensor-SupD set for its well performance in the construction of the first AND Gate. The supD PhiR73 delta expression set is on the plasmid pSB4K5, and the PO promoter-GFP is on the pSB1A2 plasmid. | ||
+ | |||
==='''Another Design of the Second AND Gate'''=== | ==='''Another Design of the Second AND Gate'''=== | ||
Another design of the second AND Gate is to make a hybrid promoter, which can be activated by salicylate, and repressed by CI434. This hybrid promoter regulates the expression of PhiR73 delta/T3pol (this time, no amber mutation). | Another design of the second AND Gate is to make a hybrid promoter, which can be activated by salicylate, and repressed by CI434. This hybrid promoter regulates the expression of PhiR73 delta/T3pol (this time, no amber mutation). | ||
+ | |||
Because what we take is the first strategy, the second design is just discussed briefly below: | Because what we take is the first strategy, the second design is just discussed briefly below: | ||
+ | |||
First, we should figure out the -35 region and the -10 region of the salicylate inducible promoter. Then, the region between -35 and -10 is replaced with a CI434 binding site. Another CI434 binding site is placed downstream of -10 region. In this way, the promoter is silenced when CI434 is bound. After CI434 is removed from the system, this hybrid promoter still needs salicylate to activate. | First, we should figure out the -35 region and the -10 region of the salicylate inducible promoter. Then, the region between -35 and -10 is replaced with a CI434 binding site. Another CI434 binding site is placed downstream of -10 region. In this way, the promoter is silenced when CI434 is bound. After CI434 is removed from the system, this hybrid promoter still needs salicylate to activate. | ||
+ | |||
+ | [[Image:PKU_Second_AND_Gate_Hybrid_Promoter.png|600px|center|thumb|fig3. Another Design of the Second AND Gate]] | ||
{{PKU_Beijing/Foot}} | {{PKU_Beijing/Foot}} | ||
- |
Latest revision as of 23:44, 17 October 2009
|
|||||||||||||
|
|||||||||||||